Sagimet Biosciences Inc Series A (SGMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Operating Expenses | 10,765 | 14,334 | 11,925 | 19,865 | 18,195 |
| Operating Income | -10,765 | -14,334 | -11,925 | -19,865 | -18,195 |
| Other Income | 1,197 | 1,426 | 1,539 | 1,689 | 1,994 |
| Pre-tax Income | -9,568 | -12,908 | -10,386 | -18,176 | -16,201 |
| Net Income Continuous | -9,568 | -12,908 | -10,386 | -18,176 | -16,201 |
| Net Income | $-9,568 | $-12,908 | $-10,386 | $-18,176 | $-16,201 |
| EPS Basic Total Ops | -0.30 | -0.40 | -0.32 | -0.56 | -0.52 |
| EPS Basic Continuous Ops | -0.29 | -0.40 | -0.32 | -0.56 | -0.52 |
| EPS Diluted Total Ops | -0.30 | -0.40 | -0.32 | -0.56 | -0.52 |
| EPS Diluted Continuous Ops | -0.29 | -0.40 | -0.32 | -0.56 | -0.52 |
| EPS Diluted Before Non-Recurring Items | -0.29 | -0.40 | -0.32 | -0.56 | -0.50 |
| EBITDA(a) | $-10,465 | $-14,262 | $-12,151 | $-20,400 | $-18,251 |